By a News Reporter-Staff News Editor at Biotech Week -- Data detailed on Immunization and Public Health have been presented. According to news reporting originating from Pittsburgh, Pennsylvania, by NewsRx correspondents, research stated, "Influenza and dengue are viral illnesses of global public health importance, especially among children. Accordingly, these diseases have been the focus of efforts to improve their prevention and control."
Our news editors obtained a quote from the research from the University of Pittsburgh, "Influenza vaccination offers the best protection against clinical disease caused by strains contained within the specific year's formulation. It is not uncommon for there to be a mismatch between vaccine strains and circulating strains, particularly with regards to the B lineages. For more than a decade, two distinct lineages of influenza B (Yamagata and Victoria) have co-circulated in the US with varying frequencies, but trivalent influenza vaccines contain only one B-lineage strain and do not offer adequate protection against the alternate B-lineage. Quadrivalent influenza vaccines (QIVs), containing two A strains (H1N1 and H3N2) and two B strains (one from each lineage) have been developed to help protect against the four strains predicted to be the most likely to be circulating. The QIV section of this article discusses epidemiology of pediatric influenza, importance of influenza B in children, potential benefits of QIV, and new quadrivalent vaccines. In contrast to influenza, a vaccine against dengue is not yet available in spite of many decades of research and development. A global increase in reports of dengue fever (DF) and its more severe presentations, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), suggest that US physicians will increasingly encounter patients with this disease. Similarities of the early signs and symptoms of influenza and dengue and the differences in disease management necessitates a better understanding of the epidemiology, clinical presentation, management, and prevention of DF by US physicians, including pediatricians."
According to the news editors, the research concluded: "The article also provides a brief overview of dengue and discusses dengue vaccine development."
For more information on this research see: Prevention and Control of Influenza and Dengue Through Vaccine Development. Pediatric Annals, 2013;42(8):172-177. Pediatric Annals can be contacted at: Slack Inc, 6900 Grove Rd, Thorofare, NJ 08086, USA (see also Immunization and Public Health).
The news editors report that additional information may be obtained by contacting D.P. Greenberg, University of Pittsburgh, Sch Med, Pittsburgh, PA, United States. Additional authors for this research include C.A. Robertson and D.M. Gordon.
Keywords for this news article include: Pittsburgh, Pediatrics, RNA Viruses, Vaccination, Pennsylvania, Dengue Fever, Epidemiology, Flu Vaccines, United States, Viral Vaccines, Dengue Vaccines, Medical Devices, Influenza Vaccines, Biological Products, Vaccine Development, Arbovirus Infections, RNA Virus Infections, Flavivirus Infections, Flaviviridae Infections
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC